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Abstract
Background: There is a need for a way to measure success in multi-modal pain therapy that researchers and
clinicians can agree upon. According to developments in health services research, operationalizing success should
take patient-reported outcomes into account. We will present a success criterion for pain therapy that combines
different patient-reported variables and includes validity measures. The usable criterion should be part of a
statistically significant and satisfactory model identifying predictors of successful pain therapy.
Methods: Routine data from 375 patients treated with multi-modal pain therapy from 2008 to 2013 were used.
The change scores of five constructs were used for the combined success criterion: pain severity, disability due
to pain, depressiveness, and physical- and mental-health-related quality of life. According to the literature, an
improvement of at least ½ standard deviation was required on at least four of the five constructs to count as
successful. A three-step analytical approach including multiple binary logistic regression analysis was chosen to
identify the predictors of therapy success with the success criterion as the dependent variable.
Results: A total of 58.1 % of the patients were classified as successful. Convergent and predictive validity data
show significant correlations between the criterion and established instruments, while discriminative validity
could also be shown. A multiple binary logistic regression analysis confirmed the feasibility; a significant model
(Chi2 (8) = 52.585; p < .001) that explained 17.6 % of the variance identified the following predictors of therapy
success: highest pain severity in the last 4 weeks, disability due to pain, and number of physician visits in the
last 6 months.
Conclusions: It is possible to develop a feasible success criterion that combines several variables and includes
patient-reported outcomes (“PROs”) with routine data that can be used in a predictor analysis in multi-modal
pain therapy. The criterion was based on basic constructs used in pain therapy and used widespread validated
self-rating instruments. Thus, it should be easy to transfer this criterion to other institutions.
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Background
Measuring therapy success is one of the most trad-
itional tasks in clinical research. This also applies to the
area of pain therapy. The operationalization of success-
ful pain therapy is handled in diverse ways: There are
research groups that use pain levels as a measure of
success (e.g. [1, 2]), whereas others operationalize suc-
cess as an increase in social functioning (i.e. ability to
engage in productive work), by using days absent due
to sickness as an indicator (e.g. [3, 4]), or by using health-
care contacts (e.g. [1, 5]). Some studies use patient-
centered measures such as quality of life [6]. Until now,
there has been no standard procedure or agreement
among clinicians who work internationally in pain therapy
about which measures to use [7] even though there are
national projects that have suggested, for example, that
one agreed-upon questionnaire consisting of different
instruments be used—for example the German Pain
Questionnaire “Deutscher Schmerzfragebogen” [8]. A sys-
tematic literature research by Deckert et al. [7] in 2013
identified 71 relevant studies reporting heterogenic out-
come measures for multi-modal pain therapy. Most stud-
ies used measures from three core health areas (physical,
mental, social health), but the number of measures that
were used ranged from one measure per study up to 34
outcome parameters in one study. In the 71 publications
that were examined, there was not one single outcome cri-
terion that was used in all of the published works [9].
However, the efficacy of multi-modal pain therapy has
already been shown, even though there is still a lack of
studies on differential indication as reported in the review
by van Geen and colleagues [6].
Thus, an agreement on the measurement and opera-
tionalization of successful multi-modal pain therapy
would be very helpful from a research perspective be-
cause this would make comparisons of effects of differ-
ent pain centers much easier and more reliable both
nationally and internationally.
There are two relatively new aspects that should be
taken into consideration when developing and suggest-
ing such a measurement tool for wide use:
1. Health Services Research agrees that success (i.e. the
“outcome”) of a therapeutic approach should no longer
be solely expert-rated [10, 11]. This development is
clearly moving in the direction of “patient-reported
outcomes” (PROs) that consider the patient’s
evaluation of the therapy outcome (e.g. [10, 12]).
Such outcomes are seen as a class of study end-points
[13] that consider a subjective view on a patient’s
satisfaction with the care/treatment that was received
[14]. Only if the patient considers the change to be “of
worth” will it be considered to be a success. On the
other hand, experts might see no improvement in
hard parameters, but patients may subjectively feel
better, have better pain coping strategies, or feel that
their subjective quality of life has improved, etc., and
hence rate their therapy outcome as successful.
Therefore, a future operationalization of success in
multi-modal pain therapy should include patient-
reported and patient-rated data. A systematic review
showed that well-implemented PROs in routine care
improved patient-provider communication and
patient satisfaction [15, 16].
2. For reasons of validity and reliability, more than one
variable/construct should be used as the criteria for
success since each individual construct will not have
the same importance for every patient. From a
methodological view, such variables should be
measured with reliable and objective instruments.
The use of already existing instruments that are also
used in other areas of clinical research would
provide practical help to clinicians internationally.
Such instruments should ideally be available in
different language versions that have been validated.
A large platform on available instruments already
exists and is freely accessible for researchers and
treatment providers: http://www.proqolid.org/.
Aims
The first aim of this work is to introduce such a pos-
sible measurement of success for multi-modal pain
therapy that includes patient-reported data and is com-
prised of different constructs. The presentation should
include empirical evaluation of the criterion.
The second aim is to test the feasibility of the success
criterion: Goal is to identify predictors of successful
multi-modal pain therapy using the newly developed
success criterion as the dependent variable.
The overall goal of having a success criterion in pain
therapy and knowing the predictors of success was to
direct patients that are suitable and will likely profit of
this intensive treatment into the therapy. For clinicians
it would be helpful to have a-priori-estimation where
they can expect success to be able to use tight resources
in the most reasonable way. Furthermore, having a
success criterion is a prerequisite for answering further
research question such as comparison of different treat-
ment centers or therapists.
Methods
Design
The data for the study constitute routine data from pa-
tients enrolled in semi in-patient treatment in the interdis-
ciplinary pain center of the University Clinic in Erlangen.
The patients participated in a five-week full-time multi-
modal pain therapy. The data that we analyzed were
collected within the time frame of January 1, 2008 to
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March 31, 2013. The patients were assessed medically by
trained pain therapists (medical doctors and psycholo-
gists) with self-reported questionnaires before patients
began therapy (“t1”) and after they completed the treat-
ment (“t2”). There were no extra data collected for study
reasons. Thus, we developed the success criterion using
only data that are already implemented in routine care.
The patients were informed about the treatment and the
kind of data collection that would accompany their ther-
apy. They gave written consent to be treated and to have
their data collected and anonymously analyzed for scien-
tific use. The data were anonymized, and the person who
implemented the data analysis did not see any person-
related information in the data and also did not see any
patients in person so that it would be impossible to form a
connection between sensitive data and real persons. The
data were treated according to the German and Bavarian
legislative rules for data protection. Routine data collec-
tion accompanies therapeutic action at the University
Clinic Erlangen as a matter of quality assurance. This is in
accordance with the ethical commission of the Friedrich-
Alexander-Universität Erlangen-Nürnberg.
Sample
In the time period set aside for this study, a total of 417
patients with a chronic pain condition were enrolled in
the 5 week multi-modal pain therapy. Data from 42
patients could not be included in the analysis because of
poor data quality—more than 50 % of the assessed vari-
ables were missing for those people. Thus, a sample of
N = 375 was available for analysis. Single missing data in
the N = 375 sample was imputed using the EM-algorithm
[17–20].
The sample was comprised of 72.5 % females. The pa-
tients had a mean age of 46.9 years (standard deviation:
11.0), 36.3 % were employed/self-employed, 16.5 % were
living alone, and 28.3 % had 12 or more years of
education.
Intervention
According to the therapeutic procedures catalogue
(“OPS”), multi-modal pain therapy is a multidisciplinary
treatment that lasts for at least seven days. It is admin-
istered to patients with chronic pain conditions (includ-
ing tumor pain) and compulsorily involves at least two
disciplines.
To be deemed suitable for this kind of treatment (e.g.
multi-modal pain therapy), patients are required to have
at least three of the following characteristics:
 manifest or impending impairment of quality of life
and/or ability to work
 failure of a uni-modal pain therapy in the patient’s
anamnestic history or failure of an operative
procedure that was administered to relieve pain, or
failure of a pain-medication withdrawal treatment
 existing pain medication dependency or abuse
 psychic comorbidity that contributes to manifesting
the pain condition
 serious somatic comorbidity
The prerequisites set forth by the German statutory
health insurance for multi-modal pain therapy require
interdisciplinary diagnostics by at least two disciplines
(compulsorily at least psychiatric, psychosomatic, or psy-
chotherapeutic) as well as the parallel application of at
least three of the following active therapeutic approaches:
psychotherapy, physiotherapy, relaxation methods, occu-
pational therapy, medical training, sensorimotor training,
work place training, therapies from the area of art (music,
building arts, etc.), or other exercise therapies [21].
Multi-modal pain therapy in Erlangen can be described
as a semi-inpatient, intensive, interdisciplinary treatment.
The program used in this study was conducted in groups
of 8 patients and lasted for 4 to 5 weeks for 6 to 8 hours
per day for a total of 5 days per week.
The program included:
 A physical exercise program (every day): general
fitness exercises, muscle strengthening exercises,
stretching
 Education (every day): anatomy, pain, and physical
and mental coping strategies
 Relaxation training (every day): progressive muscle
relaxation, applied relaxation
 Optional therapy-related drug treatment or
physiotherapy
 Individual physical counseling (once a week): vicious
circle of pain, realistic goal determination,
individually based medical therapy
 Individual psychological counseling (once a week):
cognitive-behavioral intervention, treatment of
individual emotional distress
Development of the success criterion
To come up with the combined success criterion, following
considerations were undertaken:
1. The use of valid, wide-spread and consented data in
form of patient-rated outcome variables was a
prerequisite.
2. At the end a dichotomous variable should result for
two reasons: a) facilitating clinical decision making
in the future and b) definite classification of success
and non-success for prognostic analysis
3. The algorithm resulting in a dichotomous success
variable (yes/no) should be as easy as possible to
integrate five different constructs.
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4. The change patients undergo in therapy should not
only be minimally detectable [22], but rather be
minimal clinically important.
5. Based on the literature, a distribution-based method
that is consented should be used as benchmark for a
minimal clinically important difference.
Five subcriteria
The following instruments were used to construct the
combined success criteria for multi-modal pain therapy:
1. Average pain severity in the last 4 weeks: 11-point
numeric rating scale of pain severity referring to the
“primary pain” ranging from 0 (no pain) to 10
(strongest imaginable pain) – visualized with equal
distances between the steps of the scale.
2. PDI: Pain Disability Index [16]—using an equally
graded 11-point numeric scale ranging from 0 to 10,
this scale measures the degree of impairment in
seven different areas of life due to the pain. The
mean of the seven areas is used for analysis.
3. ADS: The General (in German: “Allgemeine”)
Depression Scale [23] measures dysfunction that can
be attributed to depressive symptoms over the last
week with 20 items rated on a four-point scale in a
self-administered questionnaire. Based on adult
norms, a score of 23 points or less suggests average
functioning compared with healthy controls,
whereas a score of 24 points or more points toward
a potentially serious depressive disorder.
4. SF-36: The SF-36 Health Survey [24] was used to
operationalize health-related quality of life. It is a pa-
tient-rated questionnaire on functional health and
well-being with 36 items (see: http://www.sf-36.org/).
The physical and mental health summary measures
(computed according to the algorithm suggested by
the authors) were used.
The variables listed above were chosen because they
are widely used both nationally and internationally in
pain therapy. To operationalize the constructs of pain
severity, disability due to pain, depressiveness, and qual-
ity of life, we employed validated and widespread self-
report questionnaires to ensure that the measures could
be easily transferred to other institutions [8].
Integrating the subcriteria into a combined success criterion
Difference values were computed for the five above
mentioned constructs. Descriptive statistics for the dif-
ference values can be found in Table 1. It was necessary
to show an improvement of at least ½ standard deviation
(SD) on at least four of the five constructs of the success
criterion to count as successful (“Standard Deviation
Method”). The difference of ½ standard deviation was
used because literature suggests that this is the minimal
clinical important difference patients can achieve [25]
(independent of statistical significance) and because the
threshold of discrimination for changes appears to be
approximately that range in different instruments [26].
The chosen method of ½ SD has to subsumed under the
distribution-based methods for defining “minimal clin-
ical important differences” [27]. It was a clinical decision
to view therapy success as substantial change on most
(but not necessarily all), thus 4 out of 5, subcriteria.
While pain severity, disability, and depressiveness should
be reduced after therapy, health-related quality of life
should be higher (i.e. to show improvement). The con-
struct “depressiveness” was a special case: Here, we looked
for improvement only in patients who had been identified
as “depressive” at t1. People who had been below the cut-
off for depressiveness at t1 were counted as successful as
long as they were still below the cut-off after they
completed therapy.
The analysis of the five constructs resulted in a dichot-
omous variable incorporating a decision for each individ-
ual: successful—yes/no. Characteristics of the criterion
including percentages of patients that are defined as suc-
cesses are presented in the results section.
Instruments
In addition to the above-mentioned variables, the follow-
ing constructs were assessed and used to predict suc-
cessful pain therapy: age, sex, living situation, school
education, employment, number of affected pain regions,
localization of the primary pain, affective and sensory pain
perception, frequency of primary pain, highest pain severity
in the last 4 weeks, lowest pain severity in the last 4 weeks,
actual pain severity, subjectively acceptable pain severity
after treatment, persuasibility of pain, number of other
symptoms accompanying the pain, number of psychic co-
morbidities, Park-Index*, number of times the personal
Table 1 Descriptive statistics for the change values of the five
variables incorporated into the combined success criterion
Minimum Maximum Mean Standard
Deviation
Change in average pain
severity t2-t1
−7.00 3.11 −1.99 1.94
Change in PDI t2-t1 −8.00 4.57 −1.72 1.89
Change in ADS t2-t1 −46.00 30.00 −12.24 10.77
Change in SF-36 physical
t2-t1
−10.86 32.49 6.95 7.08
Change in SF-36 mental
t2-t1
−29.61 37.28 8.29 12.24
t1: assessment before therapy began
t2: assessment after the five-week multi-modal pain therapy was completed
PDI Pain Disability Index
ADS General Depression Scale
SF-36 SF-36 Health Survey—Health-related quality of life
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physician was changed due to failures in pain treat-
ment, number of pain-associated physician visits in the
last six months, number of other pain-related treat-
ments (excluding physicians/medical specialists) in the
last 6 months, total number of doctors involved be-
cause of pain, number of pain-associated hospital visits,
number of pain-associated rehabilitation treatments, re-
tirement request pending, current retirement payment,
disability request pending, and a work accident as the
reason for the pain condition.
*The Park-Index refers to a publication by Park et al.
[28] who describe a number of psychic comorbidities
that are positively correlated with medically unexplained
pain. These comorbidities (Alcohol use disorders, Nico-
tine Dependence, Mood disorders, Anxiety disorders,
Psychotic Disorders, Sleep disturbances) were used in
this publication to build a sum score for which a range
of 0 to 6 points is possible.
Statistical analysis
Empirical evaluation of the success criterion
To provide an empirical evaluation of the success criter-
ion percentages of patients who fulfilled a certain num-
ber of subcriteria (3, 4, 5) are presented. As a sensitivity
analysis the required change was set to one SD for each
single criterion—theoretically doubling the minimal clin-
ically important difference.
To provide figures for evaluating validity of the success
criterion, convergent validity was checked with a) nine
scales of the FESV (Questionnaire to assess pain reduc-
tion) at the end of treatment; b) with the subjective pa-
tient satisfaction at the end of treatment (single item,
higher satisfaction was coded with lower values), c) with
percentage of patients that reached a subjectively toler-
able pain level which they defined at the start of their
treatment. The FESV [29] is a self-rated, validated reliable
questionnaire measuring therapy success in the scales of
“depression reduction”, “fear reduction”, “anger reduction”,
“competences in planning”, “cognitive restructuring”, “sense
of competence”, “mental distraction”, “countersteering ac-
tivities”, “relaxation techniques”. For all convergent validity
measures correlation and inference statistics with the di-
chotomous success criterion are presented.
Furthermore predictive validity was analyzed with a)
subjective patient satisfaction with treatment one year
after discharge and b) with rating of pain severity one
year after discharge. For both correlation and inference
statistics with the success criterion at the end of treat-
ment are shown.
Discriminative validity was checked by correlation and
inference statistics with the MPSS (Chronicity state ac-
cording to Gerbershagen) rating [16]. This is a measure
for chronicity of pain and should by concept not correl-
ate with success.
Predictors of successful pain therapy
A three-step analytical approach was chosen to predict
successful pain therapy: I) Pre-analysis: Univariate ana-
lyses involving binary logistic regressions for 37 potential
predictor variables (each alone) and success (dichotom-
ous yes/no) as the dependent variable were carried out.
We decided to keep variables for further analysis if they
showed a significant (p < .05) or at least a trend toward a
significant association (p ≤ .10) with therapy success. II)
Multicollinearity: We assessed whether the in Step I sig-
nificant/trend significant variables were correlated with
the other potential predictors. To develop a parsimoni-
ous model, we decided to eliminate variables if they had
associations with other predictors of r > .500, indicating
medium and high degrees of association. The decision
about which of two variables had to be eliminated in
cases of multicollinearity was based on the degree of as-
sociation with other variables in the model. The variable
that showed higher associations with all other variables
was omitted. Thus, the remaining variables were used in
the final model. III) Final model: A multiple binary logis-
tic regression analysis was computed with the success
criterion as the dependent variable and the predictor
variables that were not associated with each other more
than r = .500 and that at least showed a trend toward be-
ing significantly associated with therapy success in the
univariate analysis.
Sensitivity analysis predictors
Furthermore, as a sensitivity analysis the variables that
had been eliminated in the above described Step I were
included in the final model one at a time, thus resulting
in analyses with 8 + 1 predictors. This analysis was con-
ducted to account for the very rare possibility that a
variable that had a non-significant univariate association
with a dependent variable could turn out to have a sig-
nificant association when it was combined with a certain
set of variables. This sensitivity analysis was computed
to provide hints about other potentially important vari-
ables that might be associated with therapy success.
Results
Success criterion
A combined success criterion incorporating the five vari-
ables pain severity, pain disability, depressiveness, and
health-related quality of life (physical and mental) was
developed.
Per definition 58.1 % of patients were counted as suc-
cessful (at least 4 out of 5 fulfilled criteria). Table 2 com-
pares the frequencies of patients who achieved success on
a certain number of the five single criteria. With a broader
definition of only 3 out 5 there would be 81 % successful,
while a minimal clinical important change in all 5 criteria
reached 28.0 %. As a sensitivity analysis Table 2 shows also
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the number of patients who improved at least 1 Standard
Deviation. Using this stricter criterion only 34.2 % would
fulfil at least 4 out of 5 criteria. Below 10 % improved at
least 1 SD in all 5 subcriteria.
The single criterion that had the highest success rate
was depressiveness. A total of 223 patients (59.5 %) were
above the cut-off before therapy, thus counting as de-
pressive. Of those, 85.0 % improved after therapy (Fig. 1).
However, 4 patients (1.1 %) who were not counted as
depressive before therapy were above the cut-off after
completing therapy and were thus counted as Non-
Responders on this single criterion. For health-related
quality of life 2/3 or less improved (65.9 % physical,
57.3 % mental).
Empirical evaluation of the success criterion
Convergent validity
The combined success criterion correlates significantly
with eight of nine scales of the FESV (Table 3). Except
for anger reduction, the patients rated as successful had
significant lower values in depression (p < .001), in fear
(p = .003), significant higher values in competences in
planning (p < .001), in cognitive restructuring (p < .001),
in sense of competence (p < .001), in mental distraction
(p = .005), in countersteering activities (p = .032) and in re-
laxation techniques (p = .004) measured with the FESV.
Therapy success correlates significantly with subjective
patient satisfaction at the end of treatment (r = -.261;
p < .01). The mean values in satisfaction between suc-
cesses (M = 1.71) and non-successes (2.13) differ signifi-
cantly (T = 5.003; p < .001).
Therapy success also correlates significantly with the
percentage of patients that reached a subjectively toler-
able pain level (Contingence coefficient = .218; p < .01).
While of those classified as successful reached 38.5 %







Combined Success Criterion Sensitivity Analysis
(1/2 SD improvement) (1 SD improvement)
Frequency (N) % Frequency (N) %
0 10 2.7 27 7.2
1 15 4.0 53 14.1
2 46 12.3 83 22.1
3 86 22.9 84 22.4
4 113 30.1 94 25.1
5 105 28.0 34 9.1
Total 375 100.0 375 100.0
















































Fig 1 Details of improvement in the constructs of the success criterion. HR-QoL: Health-Related Quality of Life. # Sample size for the depression
criterion: N = 223 (only patients who were labelled depressive before therapy began)
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their subjective tolerable pain level, in the group of
non-successes reached this only 17.8 % (Chi2 = 18.666;
p < .001)
Predictive validity
Success according to the presented criterion correlates sig-
nificantly with subjective patient satisfaction with treatment
one year after discharge (r = -.272; p < .01). Successful pa-
tients have a significantly higher rated satisfaction (displayed
in lower values because of the scale) (M= 1.88 vs. M= 2.34;
T = 3.611; p < .001) one year after finished treatment.
Furthermore a significant correlation between pain se-
verity one year after discharge and the definition as a
succeed is evident (r = -.193; p < .05). Thus patients de-
fined as successful have significantly lower pain severity
one year after discharge (M = 6.9) than patients defined
as not successful (M = 7.7) (T = 2.654; p = .009).
Discriminative validity
The Gerbershagen rating describing the chronicity of pain
is neither with the sum score (r = .046) nor with the
stadium (r = .056) significantly or clinical relevantly corre-
lated with therapy success. Successes and non-successes do
not differ in their mean sum score significantly (M= 8.91
vs. M= 8.76; T = -.822; p = .412).
Predictors of success in multi-modal pain therapy
Step 1 – Pre-Analysis: The binary-logistic regression
analyses revealed the following 9 significant predictors
of success(successes coded 1, non-successes coded 0):
affective pain perception (p = .016; OR: 1.03), average
pain severity in the last 4 weeks (p < .001; OR: 1.34),
highest pain severity in the last 4 weeks (p < .001; OR:
1.43), lowest pain severity in the last 4 weeks (p = .005;
OR: 1.13), actual pain severity (p = .003; OR: 1.14), disabil-
ity through pain (PDI) (p < .001; OR: 1.42), depressiveness
(ADS) (p = .004; OR: 1.03), mental-health-related quality
of life (SF-36) (p = .006; OR: 0.98), and number of pain-
associated physician visits in the last six months (p = .056;
OR: 0.98),. Furthermore, the two variables age (p = .097;
OR: 0.98) and school education (p = .077; OR: 1.50) were
significant at an alpha-level of .10. Detailed results for
each of the 37 regression analyses can be found in Table 4.
As a result, 11 variables were kept and used in the multi-
collinearity analysis.
Step 2 – Multicollinearity Analysis: the following vari-
ables were eliminated from the final model: depressive-
ness (r = -.764 with mental-health-related quality of life),
average pain severity in the last 4 weeks (r > .500 with
highest, lowest, and actual pain severity), and actual pain
severity in the last 4 weeks (r > .500 with highest, lowest,
and average pain severity). Thus, 8 variables remained in
the final modal.
Step 3 – Full model—multiple binary logistic regression
analysis: A significant model (Chi2 (8) = 52.585; p < .001)
that explained 17.6 % of the variance identified a total of
three variables predicting success (successes coded 1, non-
successes coded 0) in multi-modal pain-therapy: disability
due to pain (p < .001; OR: 1.36), highest pain severity in
the last 4 weeks (p = .025; OR: 1.26), and number of pain-
associated physician visits (p = .008; OR: 0.97). Patients
who were more impaired and had a smaller number of
pain-associated physician visits in the last 6 months (in
addition to the multi-modal pain therapy) had a higher
probability of success. The detailed results for the 8 pre-
dictors that were included are shown in Table 5.
Sensitivity analyses
A sensitivity analysis explored whether the variables that
had been excluded in Step 1 could have been significant
predictors of success when included one by one in the full
model with the 8 chosen variables. As a result, the 26 add-
itional variables did not change the results of the 8 chosen
variables. The three significant predictors (pain severity, dis-
ability due to pain, and physician visits) remained signifi-
cant in all cases. The variable age was a further significant
Table 3 Empirical evaluation of the success criterion—Convergent validity with the FESV at the end of therapy [29]
Successes Non-Successes T p Correlation
Mean (SD) Mean (SD)
FESV scale 1: Depression 44.42 (8.10) 49.65 (9.08) 5.869 <.001 −.291**
FESV scale 2: Fear 44.55 (7.91) 47.35 (9.37) 3.044 <.01 −.160**
FESV scale 3: Anger 48.36 (8.29) 50.08 (8.67) 1.952 n.s.a −.101
FESV scale 4: Competences in planning 61.33 (6.01) 58.90 (6.63) −3.701 <.001 .188**
FESV scale 5: Cognitive restructuring 58.12 (7.34) 54.31 (8.25) −4.715 <.001 .237**
FESV scale 6: Sense of competence 56.55 (7.37) 52.98 (8.58) −4.327 <.001 .219**
FESV scale 7: Mental distraction 57.95 (8.55) 55.38 (8.74) −2.840 <.01 .145**
FESV scale 8: Countersteering activities 53.50 (8.80) 51.49 (9.11) −2.155 <.05 .111*
FESV scale 9: Relaxation techniques 60.64 (7.41) 58.17 (8.73) −2.870 <.01 .151**
* p < .05; ** p < .01; *** p < .001
a p = .052
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predictor in the models with the additional predictors “num-
ber of pain-associated hospital visits” (age: p = .047) and “num-
ber of symptoms accompanying the pain” (age: p = .048). All
other chosen variables remained unchanged in their associa-
tions. Only one additional predictor had a significant associ-
ation with success when included in the full multivariate





Wald df p OR 95 % Confidence Interval for
OR
Lower Value Upper Value
Age −.016 .010 2.755 1 .097 0.984 0.966 1.003
Sex −.229 .237 0.933 1 .334 0.795 0.500 1.266
Living situation −.161 .280 0.331 1 .565 0.851 0.492 1.473
School education .408 .231 3.122 1 .077 1.504 0.956 2.365
Employment .145 .217 0.444 1 .505 1.156 0.755 1.769
Number of affected pain regions .001 .014 0.011 1 .918 1.001 0.974 1.029
Localization of primary pain:
head .180 .289 0.387 1 .534 1.197 0.679 2.111
upper body −.286 .217 1.738 1 .187 0.751 0.491 1.149
lower body −.103 .234 0.194 1 .660 0.902 0.571 1.427
joints .571 .377 2.288 1 .130 1.769 0.845 3.706
whole body .063 .350 0.032 1 .858 1.065 0.536 2.113
Pain perception affective (SES) .028 .012 5.842 1 .016 1.029 1.005 1.053
Pain perception sensory (SES) .001 .015 0.006 1 .936 1.001 0.972 1.031
Frequency of primary pain −.192 .238 0.655 1 .418 0.825 0.518 1.314
Average pain severity in the last 4 weeks .289 .063 20.695 1 <.001 1.335 1.179 1.511
Highest pain severity in the last 4 weeks .359 .083 18.456 1 <.001 1.431 1.215 1.686
Lowest pain severity in the last 4 weeks .126 .045 7.828 1 .005 1.134 1.038 1.239
Actual pain severity .133 .045 8.830 1 .003 1.143 1.046 1.248
Acceptable pain severity after treatment .023 .062 0.137 1 .712 1.023 0.906 1.156
Persuasibility of pain .276 .252 1.200 1 .273 1.318 0.804 2.160
Number of symptoms accompanying pain .002 .047 0.003 1 .959 1.002 0.914 1.099
Number of psychic comorbidities .142 .150 0.898 1 .343 1.153 0.859 1.547
Park-Indexa .273 .190 2.068 1 .150 1.314 0.906 1.905
Disability due to Pain (PDI) .348 .066 28.218 1 <.001 1.417 1.246 1.611
Depressiveness (ADS) .029 .010 8.387 1 .004 1.029 1.009 1.049
Physical-health-related quality of life (SF-36) −.021 .014 2.095 1 .148 0.980 0.953 1.007
Mental-health-related quality of life (SF-36) −.025 .009 7.413 1 .006 0.976 0.959 0.993
Number of personal physician switches .060 .056 1.162 1 .281 1.062 0.952 1.184
Number of pain-associated physician visits in the last six months −.023 .012 3.657 1 .056 0.977 0.954 1.001
Number of pain-related other treatments in the last 6 months −.003 .007 0.200 1 .655 0.997 0.982 1.011
Number of doctors involved because of pain −.010 .025 0.151 1 .698 0.990 0.943 1.040
Number of pain-associated hospital visits −.026 .056 0.222 1 .638 0.974 0.873 1.087
Number of pain-associated rehabilitations .027 .071 0.146 1 .702 1.027 0.894 1.180
Retirement request pending −.008 .595 0.000 1 .989 0.992 0.309 3.183
Current retirement payment −.108 .292 0.138 1 .710 0.897 0.507 1.589
Disability request pending .292 .216 1.821 1 .177 1.339 0.876 2.047
Work accident as reason for pain condition −.083 .422 0.038 1 .845 0.921 0.402 2.107
aconsists of Alcohol use disorders, Nicotine Dependence, Mood disorders, Anxiety disorders, Psychotic Disorders, Sleep disturbances: sum index with range of 0 to 6
Bold: significant at a level of p < .05 or at a level of p ≤ .10
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model: “disability request pending”. It was associated
such that success in therapy was more probable when
there was no disability request pending (p = .008).
Discussion
Success criterion
This work originated in the practical routine care of
chronic pain patients. After every block of multi-modal
pain therapy in the pain therapy center, therapists claimed
that they “somehow knew” who had benefitted and who
had not—however, this was more of a gut instinct rather
than a measurable effect. Thus, a need to be able to
operationalize success in multi-modal pain therapy was
evident. A further goal was to optimize patient recruit-
ment and allocation to an expensive specialized treatment
such as semi-inpatient multi-modal pain therapy. It was
important to know who was benefitting from such thera-
py—but in order to answer that question; agreement
about what was meant by “benefitting” was needed first.
Thus, first, there was agreement that success in multi-
modal pain therapy needed to be measured multi-modally
and thus with different constructs. Second, the measure-
ment should be implemented with constructs that had
been assessed as valid and relevant for the patient; there-
fore, patient reported outcomes were utilized. Third, the
measurement should be feasible, easy to implement within
routine care (or already implemented), valid, reliable, and
objective; therefore, we used well-known measures with
tested quality criteria that were widely used (at least in
Germany). Fourth, literature-based knowledge on minim-
ally clinical important difference should be incorporated.
As a consequence, we developed a combined success cri-
terion including five single criteria (pain severity, disability
due to pain, depressiveness, and quality of life—physical
and mental). We defined success as improvements of at
least ½ standard deviation on at least four of the five
single criteria.
A first empirical evaluation showed evident convergent
validity, predictive and discriminant validity. Patients de-
fined as successes had more favourable values than pa-
tients defined as non-successes in the instruments used
for convergent and predictive validity. The strength of
the correlations seems to be low. However, this can be
explained by the concept: correlation of a multi-domain-
construct with a single criterion. Thus, the combined
success criterion is to heterogenic to show high correl-
ation with for example pain severity.
Limitations
A critical point is that the success criterion does not in-
clude the social aspect of re-establishing the ability to
become gainfully employed or to work, which has been
used as a single success criterion in many international
studies (e.g. [3, 4]). However, this reflects the special
situation in Germany where the pressure of regaining
the ability to work might not be as high because the fi-
nancial coverage is rather long and sufficient. The
therapeutic experience in multi-modal pain therapy
often shows the opposite effect: if the therapist ex-
presses the expectation that the patient should to be
able to work again, the patient might react with a pain
“relapse” and a worsening of symptoms if the patient
believes he/she has “a right to be sick.” Therefore, the
ability to be gainfully employed should be used as a suc-
cess criterion if it is expressed by the patient (in the sense
of “PRO”) and only for such patients—but not as a general
success criterion for all.
Reflecting the results concerning therapy success, it
has to be stated that immediately after therapy comple-
tion, more than half of the patients improved markedly
on at least four of the five constructs. However, to judge
the effectiveness of multi-modal pain therapy, this result
is insufficient and needs to be validated with follow-up
data. This is a limitation at the moment. We plan to do
Table 5 Full model (Step 3)—Multiple binary logistic regression analysis with combined success criterion as the dependent variable
Regression
Coefficient β






Age −.020 .011 3.481 1 .062 0.981 0.960 1.001
School education .430 .262 2.695 1 .101 1.537 0.920 2.569
Pain perception affective (SES) −.011 .015 0.499 1 .480 0.990 0.961 1.019
Lowest pain severity in the last 4 weeks −.029 .057 0.250 1 .617 0.972 0.868 1.088
Highest pain severity in the last 4 weeks .229 .102 5.013 1 .025 1.257 1.029 1.535
Disability due to Pain (PDI) .306 .077 15.803 1 <.001 1.358 1.168 1.580
Mental-health-related quality of life (SF-36) −.017 .010 2.746 1 .098 0.983 0.964 1.003
Number of pain-associated physician visits in the last six
months
−.036 .014 6.947 1 .008 0.965 0.939 0.991
Bold: significant at a level of p < .05
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this as soon as the routine data are available, and the re-
sults will be published consequently. However, the mean
amount of change in the single criteria is comparable to
results reported in the literature with pain patients
treated with several diverse treatments concerning the
mental health related quality of life [30, 31], physical
health related quality of life [30, 32], pain severity [33]
and functioning [34].
A further limitation is, besides that it concerns in this
manuscript data of a single center, that we were bound
to the assessment instruments implemented in routine
pain care. The advantage of this on the other hand is
that those instruments are used in all multimodal pain
therapy centers in Germany because of the dissemin-
ation of the German Pain Questionnaire [8] and thus
transferability of the criterion was easily given.
With the decision for ½ standard deviation as minimal
clinically important difference (MCID) there might be a
certain amount of change that is undetected since the
MCID is not equivalent with the minimally detectable
change [22]. For the latter we would have needed to
count even 1-point-changes in each of the five measures.
This has methodological problems though, since a) the
scaling of the five instruments is not equivalent and b)
the rate of measurement errors/differences in measure-
ment by chance seen as clinical relevant improvement
would have afflicted validity of the success criterion.
The presented combined success criterion has to be seen
as a first (pilot) version. Adaption of the criterion concern-
ing number and kind of included single criteria might be
necessary depending on the results of further examination:
a) in other treatment centers, b) with follow-up data
c) when routine assessment instruments are changed.
Up to now our approach of measuring success does
not reflect individual patient preferences and/or goals. It
would also be an adaptation possibility to define success
in the single criteria more dependent on the change
goals of the patient himself.
In conclusion, we developed a feasible, combined, PRO-
success criterion for multimodal pain therapy. However,
the challenge will be to raise awareness in practical work-
ing pain therapy centers that there is a need for such a cri-
terion and a need for comparable outcome measures. Even
though the pain research community frequently asks “that
a standard outcome be used across pain studies” [35] and
“for more systematic assessment” [36], work by Deckert
and colleagues has shown a great deal of diversity in how
success is measured in multi-modal pain therapy [7, 9].
Thus, the ongoing multi-center, federally funded, VAPAIN-
project will hopefully raise awareness of this gap [37].
Predictors of therapy success
Concerning the predictors, we found that the patients
with especially heavy burdens profited the most. Patients
with more severe pain when therapy began and with lar-
ger impairments in their daily life functioning due to
their pain were associated with a higher probability of
therapy success. There could be two reasons for these
findings. One is a methodological one: People with high
scores on the pain severity and pain impairment scales
had better chances of improving substantially than pa-
tients who began with low scores (ceiling effect). The
second reason is a motivational one: pain therapists fre-
quently report that patients who are seriously impaired
and bothered by their dysfunction have the highest levels
of motivation to change their lives. To a large degree,
multi-modal pain therapy is about changing habits. Chan-
ging habits is not easy and is often inconvenient. Thus, a
patient must be motivated (see Transtheoretical Model
according to Prochaska & DiClemente [38]) to bridge the
intention-action gap. From Motivational Interviewing ac-
cording to Miller & Rollnick [39], it is known that the will
to change has to come from the patient himself/herself,
and therapists can only support patients by bringing up
the topic of change. Such motivation seems to be more
prevalent in patients who are enduring a great deal of suf-
fering from their pain condition and whose secondary gain
from illness is rather low. There is support from the litera-
ture that the readiness to self-manage pain is an important
predictor of the completion [40] of and the functional out-
come [41] of a treatment program.
Like our study, a study from the Netherlands also
found that high scores on disability were associated with
recovery five and 12 months after therapy in patients
with chronic nonspecific low back pain [42]. A German
study of fibromyalgia patients also confirmed this associ-
ation: higher impairment at baseline was predictive of a
clinically significant decrease in impairment after treat-
ment; greater physical impairment prior to treatment
increased the likelihood of having a substantial decrease
in functional impairment due to pain after therapy was
completed by about 4.24 times [43]. Furthermore, an-
other study of chronic pain patients reported a better
prognosis for patients with a higher baseline pain score
just as we found [44]. On the other hand, the “pain score”
(in the sense of higher values implying higher pain sever-
ity) seems to be associated with an unsuccessful return to
work in patients with low back pain after an inpatient hos-
pital intervention [45]. However, we need to ask whether
“the ability to be gainfully employed” should be used as a
single outcome.
The third significant predictor of success after complet-
ing therapy in our study was the number of pain-related
physician visits in the last six months. Success was higher
for patients with a smaller number of doctors visits. The
interpretation could be that highly impaired pain patients
had stopped visiting doctors for out-patient care because
they had decided that such visits were not helping them.
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So perhaps they were focusing on this planned intensive
semi-inpatient 5-week multi-modal treatment and had
put a lot of their hopes in that specific therapy and were
therefore highly motivated to succeed. One early study
also reported results in this direction: especially non-
depressed patients with chronic pain seemed to profit
from treatment if they had fewer previous types of treat-
ment [46]. In another study [44], a worse prognosis was
reported for chronic pain patients who had had more
treatment in the past.
There is a frequently recycled discussion in pain therapy
about whether patients who are in the process of applying
for disability pension should be included in multi-modal
pain therapy. The hypothesis is that those patients will
not/cannot improve because of their conflict of interest.
There are studies from Denmark supporting this hypoth-
esis [47, 48]. However, our results from the main analysis
do not confirm this hypothesis. Neither a pending retire-
ment request nor a pending disability request was univari-
ately significantly associated with therapy success. Thus,
excluding such patients in the first place does not appear
to be justified. However, we found in a sensitivity analysis
that therapy success may be more probable when there is
no disability claim pending.
In our study, younger age showed a trend toward being
associated with a higher probability of therapy success.
This direction of association has also been reported in
other studies (e.g. [42, 44]).
Interestingly, the Patient-Reported Outcome (PRO)
that we focused on in this study with regard to the success
of multi-modal pain therapy still seems to be different
from therapy satisfaction as one Australian study had sug-
gested [49].
In conclusion, there are not many published works
that have focused on the predictors of success in multi-
modal pain therapy. The works cited in our discussion
make reference to other pain management strategies,
unimodal approaches, or rather unspecific pain therapy
concepts. As Morasco and colleagues stated in their re-
view: “Limited data are available to identify predictors of
treatment outcome” [50].
Conclusions
From the perspectives of both researchers and clinicians, a
combined “PRO” criterion for assessing success in multi-
modal pain therapy is desirable. There are two reasons for
this: 1) it models the multifactorial genesis and therapy of
chronic pain better than one single category criterion, and
2) a decision about whether a patient is considered a suc-
cess or not is necessary for almost all analyses that would
follow such as differences in outcomes between different
patient collectives, observation of long-term outcomes of
applied health services, etc. The combined success criter-
ion that we developed involves well-established constructs
whose measurement is implemented in routine care in
pain treatment centers. A first empirical evaluation con-
firms evidence of content validity.
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